Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Ipsen bolsters rare disease pipeline in €700m Memo takeover | PharmaVoice

Pharma Tech

Ipsen bolsters rare disease pipeline in €700m Memo takeover

Jul 2, 2026, 12:19 PM

Read Full Article → Ipsen bolsters rare disease pipeline in €700m Memo takeover

Ipsen bolsters rare disease pipeline in €700m Memo takeover

Translate article text

Choose a language and wait for the translated text.

Ipsen’s Memo acquisition is the second the former has signed this week alone, following its blockbuster Kartos buyout on 29 June.